Similarly, in lung cancer, radioresistance-related signatures also predict patient outcomes and immune status (31), identifying TOP2A, CDH3, ASPM, CENPF, SLC2A1, and PRC1 as potential detection biomarkers for early lung cancer (32). The gene discussed is SLC2A1; the disease is lung cancer.